Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
about
Clinical relevance and public health significance of hepatitis B virus genomic variationsClinical significance of hepatitis B surface antigen mutantsRole of Marine Natural Products in the Genesis of Antiviral AgentsHepatitis B Virus Infection, MicroRNAs and Liver DiseaseMicroRNAs may solve the mystery of chronic hepatitis B virus infectionClinical impact of occult hepatitis B virus infection in immunosuppressed patientsSeroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in ZimbabweNew genetic associations detected in a host response study to hepatitis B vaccineCommentary: eight ways to prevent cancer: a framework for effective prevention messages for the publicMutation profiling of the hepatitis B virus strains circulating in North Indian populationHepatitis B virus infection in Latin America: a genomic medicine approachLong-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescenceIdentification of Novel A2/C2 Inter-Genotype Recombinants of Hepatitis B Virus from a Korean Chronic Patient Co-Infected with Both Genotype A2 and C2.Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in ItalyClinical implications of hepatitis B virus mutations: recent advances.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009.The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.The increasing burden of imported chronic hepatitis B--United States, 1974-2008.Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy.Hepatocyte death: a clear and present danger.Alanine aminotransferase is an inadequate surrogate marker for detecting lamivudine resistanceSimultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assayA population based study on hepatitis B virus in northern iran, amolLow immune response to hepatitis B vaccine among children in Dakar, SenegalClassification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis.Role of IL-4 gene polymorphisms in HBV-related hepatocellular carcinoma in a Chinese population.The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiologyGlucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells.Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections.Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analysesHealth literacy in patients with chronic hepatitis B attending a tertiary hospital in Melbourne: a questionnaire based surveyHigh burden of hepatitis B infection in Northern Uganda: results of a population-based survey.Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirusOccult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China.Post-partum reactivation of chronic hepatitis B virus infection among hepatitis B e-antigen-negative women.Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity
P2860
Q24644176-2256D89F-F484-488B-80C3-2C5D9462A2D0Q26773676-EF544428-75F2-478D-B014-0749FEE55901Q26796360-96979661-5F3D-4022-B65B-5D242A99C918Q26801511-7BBF699F-0C60-4028-AAE1-92272E20CD0FQ26827668-C7ABDCE8-9FAB-419A-8DD0-0959D810FBE8Q27006996-6204DD8D-6620-460A-8AE9-0770504A3F75Q27490198-3F7FB918-BC06-4E18-9061-148F1136E5CDQ28276283-4599C75B-05C2-45B5-BA0C-816C5BC254A4Q28384529-37D9E208-2557-43D6-8E5C-F88F8C306E77Q28540948-F1102D2A-F40A-4101-B8B4-BDADCC354343Q28657861-2AE69A64-DA7E-46FD-A064-F5DF3692E455Q33294724-E1D9DFB8-BE45-4353-9494-F3C144E355BBQ33624430-26749BD5-43BF-433D-B75A-B247271D5494Q33780105-795911FA-CFB6-41E2-A74D-55ECF79501C5Q33801300-07D8AF0A-ADA9-4B36-8241-22E854BC25BBQ33801311-9979A8E9-78F5-4107-A487-3BBAFAAFFAB7Q33866448-B7DD39AF-6A2E-4DE3-8E1D-C6348678EF0CQ33912906-58C195AC-6747-42DC-AF91-32028DEF55EDQ33988130-EED0E41B-4598-40A8-9332-E19095CD6D33Q34064400-68BB94E9-35B0-4B09-B27E-BA599718A48DQ34098106-8EBE789B-AC10-4A7B-A070-0B58EDDA70EFQ34130388-21896703-8985-4E18-91FB-A71B1D0F7F8BQ34147508-BCC018BC-C11A-4A58-A04B-38D38198DB19Q34183191-7F8E3A95-6230-43B8-8AE8-E3AB66D65069Q34190419-086EC60D-0719-46A3-A53E-28698A94990BQ34196708-E0536753-529D-43A3-9DF0-D4EE27C64D7FQ34292847-07E75B46-3F50-4AF2-8D59-CC94A0DAFAC6Q34302199-A04E3893-69B1-4068-9B70-45EE68A82FF6Q34309028-3EB8D082-1A04-4EB9-AA54-8ACF0FB4BFEFQ34338519-5E8367F4-AC9A-46AE-9C45-E1F1C13EA50AQ34552627-2DF6659A-1AA6-450C-BECC-635B77C79D38Q34683065-29D07F0A-3EC0-4C09-B120-B93C192F0764Q34716864-CC47A277-2E19-49A8-9B26-0D2AF58AD89AQ34769837-B5E2E58D-2C50-4D6C-BC4C-41EBC17A72C9Q34874060-91117B36-F816-4506-9BCB-1C92520E2533Q34899224-BDDEB269-22AE-47AC-A3D8-897337958EBDQ34933721-97EA79D5-A436-4113-9EFD-8CA9803A6A07Q34947605-8B821C78-F2EF-4A5D-A25B-3BD0005193F5Q35012120-413A3B74-E7AF-48EC-8CCD-64996459BE93Q35069462-31415181-6BFF-4CDA-AE31-DDD6555E6981
P2860
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
@ast
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
@en
type
label
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
@ast
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
@en
prefLabel
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
@ast
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
@en
P1476
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.
@en
P2093
Lavanchy D
P356
10.1016/S1386-6532(05)00384-7
P478
34 Suppl 1
P577
2005-12-01T00:00:00Z